Marshall Wace North America’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-17,142
Closed -$140K 1657
2020
Q3
$140K Buy
+17,142
New +$140K ﹤0.01% 1152
2020
Q1
Sell
-36,418
Closed -$357K 1677
2019
Q4
$357K Buy
+36,418
New +$383K ﹤0.01% 875
2019
Q1
Sell
-126,555
Closed -$1.22M 1987
2018
Q4
$1.22M Buy
+126,555
New +$1.41M 0.01% 567
2017
Q2
Sell
-169,525
Closed -$2.2M 1496
2017
Q1
$2.2M Buy
+169,525
New +$2.01M 0.02% 563
2013
Q4
Sell
-14,273
Closed -$212K 866
2013
Q3
$212K Buy
+14,273
New +$215K 0.01% 551

Other funds holding MDRX

Marshall Wace North America's MDRX Position: Q4 2020 in Review

Marshall Wace North America sold out of Veradigm Inc. Common Stock (MDRX) in Q4 2020, closing a stake of 17,142 shares — an estimated $140K sold.

Marshall Wace North America first reported a position in MDRX in Q3 2013 and held it in 5 quarters. The position peaked at $2.2M in Q1 2017. 217 funds tracked by Wall St. Rank hold MDRX as of Q4 2020.

  • Marshall Wace North America reported no remaining Veradigm Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Marshall Wace North America sold 17,142 Veradigm Inc. Common Stock shares in Q4 2020, an estimated $140K.
  • Marshall Wace North America first reported a position in Veradigm Inc. Common Stock in Q3 2013 and held it in 5 quarters.
  • Marshall Wace North America's Veradigm Inc. Common Stock position peaked at $2.2M in Q1 2017.
  • 217 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.